FDA reports new drug safety evaluations

Photos

SPRA-GROUP

see larger image

uploaded by shyamdash

• 

  uploaded by shyamdash | add comment

• 

  uploaded by debwire | add comment

• 

  uploaded by incurable_hippie | add comment

• 

  uploaded by adamrhoades | add comment

• 

  uploaded by Legendary Classic | add comment

• 

  uploaded by Legendary Classic | add comment

• 

  uploaded by bahketni | add comment

• 

  uploaded by tanaka13 - Créations du Net | add comment

• 

  uploaded by elb_the_prof | add comment

• 

  uploaded by shyamdash | add comment

The quarterly reports are now being released to alert consumers to drugs that are on the FDA's watchlist and are currently undergoing testing.  This move towards quarterly reporting is a direct response to a call for increased transparency when it comes to their drug safety investigations.  While there is a concern that patients may react negatively if they discover a drug they are taking is named in the quarterly reports, the FDA has noted that inclusion of a drug in the report does not necessarily mean it is harmful - just that the FDA is responding to submissions from their Adverse Event Reporting System (AERS) and investigating accordingly.

The first list, for January-March 2008, was released 6 months late.